Press Releases

Date	Title	Company
16-Jun-2023	Europe Pelvic Floor Diagnostics Market is projected to total US$ 2,056.74 Million in 2023	MARKITWIRED
16-Jun-2023	Americas COVID-19 Testing Market is likely to be valued at US$ 9.8 billion by 2033	MARKITWIRED
16-Jun-2023	Pelvic Floor Stimulators Market is estimated to grow at a CAGR of 8.8% between 2023 to 2033	MARKITWIRED
16-Jun-2023	Ocular Drug Delivery System Market sales will total US$ 27.82 Billion by 2031 \| Says Future Market Insights	MARKITWIRED
16-Jun-2023	Stereotactic Planning Software Spending Analysis Market valuation is expected to reach US$ 128.2 Million by 2031 \| Get Insights FMI	MARKITWIRED
16-Jun-2023	Ophthalmic Eye Drops Market is estimated to be valued at US$ 16.21 Billion in 2023	MARKITWIRED
16-Jun-2023	Value-Based Healthcare Services Market is expected to reach a valuation of US$ 20.5 Billion by 2033	MARKITWIRED
16-Jun-2023	Centrifugal Blood Pump Market is likely to expand at a 4.0% value CAGR by 2033	MARKITWIRED
16-Jun-2023	Fiducial Markers Market to reach a valuation of ~US$ 408.3 Million by the year 2033	MARKITWIRED
16-Jun-2023	Intrauterine Insemination Devices Market is expected to be valued at US$ 40.5 Million in 2023	MARKITWIRED
16-Jun-2023	RELIEF THERAPEUTICS Holding SA Announces CHF 5 Million Private Placement	Relief Therapeutics Holding SA
16-Jun-2023	Takeda und HUTCHMED geben die Genehmigung des Zulassungsantrags für Fruquintinib zur Behandlung von metastasierendem Dickdarmkrebs durch die Europäische Arzneimittelagentur bekannt	Businesswire
16-Jun-2023	U.S. Food and Drug Administration Approves Addition of Positive Data from Phase 3 VALOR-HCM Study to CAMZYOS® (mavacamten) Label	Businesswire
16-Jun-2023	Takeda and HUTCHMED Announce Publication of Phase 3 FRESCO-2 Results in The Lancet	Businesswire
16-Jun-2023	FDA Approves Genentech’s Columvi, the First and Only Bispecific Antibody With a Fixed-Duration Treatment for People With Relapsed or Refractory Diffuse Large B-cell Lymphoma	Businesswire
16-Jun-2023	Takeda e HUTCHMED Anunciam Pedido de Autorização de Comercialização do Fruquintinibe para Câncer Colorretal Metastático Tratado Anteriormente Validado pela Agência Europeia de Medicamentos	Businesswire
16-Jun-2023	Resource Label Group Expands Pharmaceutical offering with acquisition of Pharmaceutic Litho and Label Company	Businesswire
15-Jun-2023	SQZ Biotechnologies to Consolidate Shares with 1-for-10 Reverse Stock Split	Businesswire
15-Jun-2023	WorkJam Announces CEO Steven Kramer as EY Entrepreneur Of The Year® 2023 Québec Finalist	Businesswire
15-Jun-2023	Abivax receives “Capital Market Transaction of the Year Award” at the European Mediscience Awards 2023	ABIVAX